SYVC.US Synovics Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
0.0182 USD
Close of Jun 18, 2025
0.0001 0.0001
Market cap
USD 543K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2009.

Is SYVC.US undervalued?

Graham number

The Graham number of Synovics Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Synovics Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Synovics Pharmaceuticals Inc yet.

Synovics Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Synovics Pharmaceuticals Inc

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States…

Full company profile